NCT00241319View on ClinicalTrials.gov

Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2005

Conditions
Allergic Conjunctivitis
Interventions
DRUG

R89674 (generic name not yet established)

Trial Locations (5)

Unknown

Indianapolis

Lewiston

Rochester

Charlotte

Philadelphia

All Listed Sponsors
lead

Vistakon Pharmaceuticals

INDUSTRY

NCT00241319 - Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis | Biotech Hunter | Biotech Hunter